Jeffrey R. Currier

3.9k total citations
87 papers, 1.9k citations indexed

About

Jeffrey R. Currier is a scholar working on Immunology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jeffrey R. Currier has authored 87 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 37 papers in Infectious Diseases and 37 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jeffrey R. Currier's work include Mosquito-borne diseases and control (37 papers), HIV Research and Treatment (35 papers) and Immune Cell Function and Interaction (31 papers). Jeffrey R. Currier is often cited by papers focused on Mosquito-borne diseases and control (37 papers), HIV Research and Treatment (35 papers) and Immune Cell Function and Interaction (31 papers). Jeffrey R. Currier collaborates with scholars based in United States, Thailand and Germany. Jeffrey R. Currier's co-authors include Josephine H. Cox, Deborah L. Birx, Mary Ann Robinson, Heather Friberg, Nelson L. Michael, Ellen Kuta, Michael A. Eller, Mary Marovich, Guido Ferrari and Sylvia Janetzki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jeffrey R. Currier

85 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey R. Currier United States	26	1.0k	721	590	431	422	87	1.9k
Isabelle Staropoli France	21	643 0.6×	491 0.7×	771 1.3×	402 0.9×	466 1.1×	37	2.0k
Sarah J. Schlesinger United States	13	1.5k 1.5×	443 0.6×	700 1.2×	524 1.2×	567 1.3×	21	2.4k
Eleonora Tresoldi Italy	18	1.2k 1.2×	938 1.3×	461 0.8×	213 0.5×	261 0.6×	27	2.0k
Zdeněk Hel United States	27	1.3k 1.3×	1.1k 1.5×	540 0.9×	211 0.5×	468 1.1×	47	2.4k
Xiao‐Ning Xu United Kingdom	30	1.3k 1.3×	760 1.1×	1.2k 2.1×	846 2.0×	523 1.2×	55	3.1k
Colin Havenar‐Daughton United States	21	1.8k 1.8×	567 0.8×	706 1.2×	157 0.4×	484 1.1×	27	2.6k
Rebecca M. Lynch United States	22	917 0.9×	986 1.4×	476 0.8×	123 0.3×	333 0.8×	45	1.7k
Erika Hammarlund United States	16	944 0.9×	877 1.2×	369 0.6×	157 0.4×	738 1.7×	24	2.0k
Marion Sourisseau United States	22	980 1.0×	727 1.0×	1.3k 2.2×	1.4k 3.1×	428 1.0×	28	2.9k
Ross Lindsay United States	13	1.2k 1.2×	207 0.3×	458 0.8×	231 0.5×	355 0.8×	26	1.8k

Countries citing papers authored by Jeffrey R. Currier

Since Specialization

Citations

This map shows the geographic impact of Jeffrey R. Currier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey R. Currier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey R. Currier more than expected).

Fields of papers citing papers by Jeffrey R. Currier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey R. Currier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey R. Currier. The network helps show where Jeffrey R. Currier may publish in the future.

Co-authorship network of co-authors of Jeffrey R. Currier

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey R. Currier. A scholar is included among the top collaborators of Jeffrey R. Currier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey R. Currier. Jeffrey R. Currier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Machmach, Kawthar, Rohit Farmer, Sucheta Godbole, et al.. (2025). NK cell activation and CD4+ T cell α4β7 expression are associated with susceptibility to HIV-1. Journal of Clinical Investigation. 135(15).

Morwitzer, M. Jane, Ying Zheng, Heather Friberg, & Jeffrey R. Currier. (2025). Applications and insights from continuous dengue virus infection in a stable cell line. Frontiers in Immunology. 16. 1618650–1618650. 1 indexed citations

Middleton, Frank A., et al.. (2024). Dengue Virus Structural Proteins Are Expressed on the Surface of DENV-Infected Cells and Are a Target for Antibody-Dependent Cellular Phagocytosis. Open Forum Infectious Diseases. 12(1). ofae720–ofae720. 2 indexed citations

Mathew, Anuja, Henrik Salje, David A. Sousa, et al.. (2024). Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity. The Journal of Infectious Diseases. 230(5). 1147–1156. 7 indexed citations

Waickman, Adam T., Hengsheng Fang, Jeffrey R. Currier, et al.. (2024). Low-dose dengue virus 3 human challenge model: a phase 1 open-label study. Nature Microbiology. 9(5). 1356–1367. 9 indexed citations

McElvany, Benjamin D., Jeffrey R. Currier, Heather Friberg, et al.. (2024). B cell receptor dependent enhancement of dengue virus infection. PLoS Pathogens. 20(10). e1012683–e1012683. 4 indexed citations

Li, Yifan, Suzanne E. Wollen-Roberts, Thembi Mdluli, et al.. (2023). Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine. EBioMedicine. 97. 104815–104815. 3 indexed citations

Roy, Nathan H., et al.. (2023). Soluble NS1 Antagonizes IgG- and IgA- Mediated Monocytic Phagocytosis of DENV Infected Cells. The Journal of Infectious Diseases. 228(1). 70–79. 7 indexed citations

Waickman, Adam T., Tao Li, Heather Friberg, et al.. (2022). mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates. JCI Insight. 7(13). 5 indexed citations

10.

Waickman, Adam T., Hengsheng Fang, Jeffrey R. Currier, et al.. (2022). Evolution of inflammation and immunity in a dengue virus 1 human infection model. Science Translational Medicine. 14(668). eabo5019–eabo5019. 23 indexed citations

11.

Adam, Awadalkareem, Mary Masterson, Zoë L. Lyski, et al.. (2021). Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity. Immunology. 164(2). 386–397. 10 indexed citations

12.

Shrivastava, Shikha, Zhongyan Lu, Alexander Anderson, et al.. (2021). SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses. npj Vaccines. 6(1). 151–151. 53 indexed citations

13.

McCracken, Michael K., Gregory D. Gromowski, Lindsey S. Garver, et al.. (2020). Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques. PLoS neglected tropical diseases. 14(4). e0008191–e0008191. 19 indexed citations

14.

Adam, Awadalkareem, Marcia Woda, Sonia Kounlavouth, et al.. (2018). Multiplexed FluoroSpot for the Analysis of Dengue Virus– and Zika Virus–Specific and Cross-Reactive Memory B Cells. The Journal of Immunology. 201(12). 3804–3814. 17 indexed citations

15.

Nilsson, Charlotta, Karina Godoy‐Ramirez, Bo Hejdeman, et al.. (2013). Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees. AIDS Research and Human Retroviruses. 30(3). 299–311. 23 indexed citations

16.

Eller, Michael A., Leigh Anne Eller, Silvia Ratto‐Kim, et al.. (2012). Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(1). 9–18. 6 indexed citations

17.

Eller, Michael A., Leigh Anne Eller, Benson J. Ouma, et al.. (2009). Elevated Natural Killer Cell Activity Despite Altered Functional and Phenotypic Profile in Ugandans With HIV-1 Clade A or Clade D Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(4). 380–389. 44 indexed citations

18.

Rutebemberwa, Alleluiah, Julian W. Bess, Bruce K. Brown, et al.. (2007). Evaluation of Aldrithiol-2-Inactivated Preparations of HIV Type 1 Subtypes A, B, and D as Reagents to Monitor T Cell Responses. AIDS Research and Human Retroviruses. 23(4). 532–542. 19 indexed citations

19.

Tovanabutra, Sodsai, Jeffrey R. Currier, Josephine H. Cox, et al.. (2006). Circulating and Unique Recombinant Forms of HIV Type 1 Containing Subsubtype A2. AIDS Research and Human Retroviruses. 22(7). 695–702. 10 indexed citations

20.

Currier, Jeffrey R., Matthew E. Harris, Josephine H. Cox, et al.. (2005). Immunodominance and Cross-Reactivity of B5703-Restricted CD8 T Lymphocytes from HIV Type 1 Subtype C-Infected Ethiopians. AIDS Research and Human Retroviruses. 21(3). 239–245. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact